Lipoprotein(a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up.

ABSTRACT:

Aims

Lipoprotein(a) [Lp(a)] levels are generally constant throughout an individual's lifetime, and current guidelines recommend that a single measurement is sufficient to assess the risk of coronary artery disease (CAD). However, it is unclear whether a single measurement of Lp(a) in individuals with acute myocardial infarction (MI) is indicative of the Lp(a) level six months following the event.

Methods and results

Lp(a) levels were obtained from individuals with non-ST-elevation myocardial infarction (NSTEMI) or ST-elevation myocardial infarction (STEMI) (n = 99) within 24 h of hospital admission and after six months, who were enrolled in two randomized trials of evolocumab and placebo, and in individuals with NSTEMI or STEMI (n = 9) who enrolled in a small o

SUBMITTER: Ziogos E 

PROVIDER: S-EPMC10122422 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature